A bold early-stage project aiming to develop lab-grown lungs—which could bring fresh hope to people with pulmonary diseases such as asthma and lung cancer—has been awarded $1.5 million over three years from the Paul G. Allen Frontiers Group. The effort will be led by researchers at Boston University’s College of Engineering and School of Medicine.
The latest publication from the Kotton lab detailing the transcriptomic programs of iPSC-derived alveolar cells
Dysfunction of alveolar epithelial type 2 cells (AEC2s), the facultative progenitors of lung alveoli, is
